查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089767

注射筆市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2026-2033 年）

Injection Pen Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

注射筆市場概述

全球注射筆市場預計到 2025 年將達到 425 億美元，從 2026 年的 453 億美元成長到 2033 年的 764 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 7.7%。

到2025年，北美注射筆市場將佔據全球市場最大佔有率，達到44.8%。骨質疏鬆症、糖尿病、心血管疾病和多發性硬化症等慢性病患者數量的增加，推動了對注射筆的需求。

胰島素注射筆是治療需要頻繁給藥的慢性疾病的理想選擇。推動市場成長的另一個因素是創新可重複使用胰島素注射筆的日益普及以及對自動注射筆需求的成長。由於自動注射筆在給藥方面具有安全、簡便、便捷和精準的優點，醫療專業人員擴大採用它們。隨著全球糖尿病患者人數的增加和病情的惡化，胰島素注射的需求也不斷上升。例如，根據健康指標與評估研究所 (IHME) 的數據，全球有超過 5 億人患有糖尿病，影響著各國各個年齡層和性別的人。預計未來 30 年，這一數字將超過 13 億，糖尿病預計將成為十大死因和殘疾原因之一。目前，全球糖尿病盛行率為 6.1%。此外，根據美國國立衛生研究院 (NIH) 的數據，用於治療第 2 型糖尿病的胰島素注射筆的銷售量已經超過了胰島素管瓶的銷售量。注射裝置廣泛用於糖尿病患者的日常胰島素自我注射。當患者從管瓶注射胰島素時，往往更傾向於使用注射筆而非注射器，因為注射筆操作簡單。因此，隨著糖尿病盛行率的上升，注射筆的使用量也不斷增加。

此外，類風濕性關節炎等自體免疫疾病發生率的上升也推動了胰島素筆需求的激增。類風濕性關節炎的全球盛行率約為0.5%至1%，而生物製藥的需求正在促進胰島素筆的普及。同樣，生長激素缺乏症需要頻繁注射，這也促進了市場擴張，胰島素筆因其注射精準度高、注射過程中不適感小而備受青睞。

技術進步正在革新市場。劑量記憶、可變劑量設定和符合人體工學的設計等功能正在提高患者的依從性和便利性。例如，2024年5月，Eisai及其子公司日本美達克有限公司在日本推出了「Metject皮下注射筆」。這款用於治療類風濕性關節炎的胺基甲基葉酸（MTX）自行注射筆是日本首款此類產品，旨在減輕患者負擔並提高自行注射的安全性。該產品有多種劑量可供選擇，於2024年2月獲得生產和銷售許可，並被列入日本國民健康保險藥品價格清單。日本有70萬至80萬類風濕性關節炎患者，這款創新注射筆滿足了該領域一項重要的治療需求。

在健康意識增強和慢性病患病率上升的推動下，該行業正經歷顯著的區域擴張。 2024年1月，巴西生物製藥公司Cristalia推出了一款可重複使用的筆式注射器，用於其與Nemera合作開發的生物類似生長激素。此類合作凸顯了以在地化解決方案滿足特定市場需求的重要性。此外，對新興市場投資的增加、藥物輸送技術的進步以及對患者友善醫療設備的需求，都在推動該地區的成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：注射筆市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 注射筆市場分析工具

第4章：注射筆市場：產品具體估算與趨勢分析

  • 注射筆市場：產品特定波動分析
  • 注射筆市場：產品展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 拋棄式的
  • 可重複使用的

第5章：注射筆市場：按應用分類的估算與趨勢分析

  • 注射筆市場：基於應用領域的波動分析
  • 注射筆市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 糖尿病
  • 過敏反應
  • 骨質疏鬆症
  • 生長激素缺乏症
  • 關節炎
  • 其他

第6章：注射筆市場：依最終用途分類的估算與趨勢分析

  • 注射筆市場：按最終用途分類的波動分析
  • 注射筆市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院
  • 診所
  • 居家醫療

第7章：注射筆市場：區域估算與趨勢分析

  • 區域儀錶板
  • 區域注射筆市場波動分析
  • 注射筆市場：區域預測與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • BD
    • Eli Lilly and Company
    • Ypsomed AG
    • Biocon
    • Pfizer Inc.
    • Novartis AG
    • Novo Nordisk A/S
    • Sanofi
    • Owen Mumford Ltd.
    • Merck KGaA
Product Code: GVR-2-68038-445-1

Injection Pen Market Summary

The global injection pen market size was valued at USD 42.5 billion in 2025 and is projected to grow from USD 45.3 billion in 2026 to USD 76.4 billion by 2033, at a CAGR of 7.7% from 2026 to 2033. North America injection pen industry held the largest share of 44.8% of the global market in 2025. A rising number of chronic diseases, such as osteoporosis, diabetes, cardiovascular disease, and multiple sclerosis, are driving the demand for injection pens.

Injector pens are ideal for chronic conditions that require frequent dosing. Another factor propelling the market is the growing utilization of innovative reusable injection pens and the growing demand for automated injection pens. Medical practitioners are turning to automated injection pens owing to their safety, simplicity, convenience, and accuracy in administering medication. A growing number of diabetic patients and their seriousness worldwide has necessitated the demand for insulin injections. For instance, according to the Institute for Health Metrics and Evaluation, over 500 million individuals globally have diabetes, impacting people of all ages and genders in every nation. This number is expected to surpass 1.3 billion in the next three decades, with diabetes becoming one of the top 10 causes of death and disability, with a current global prevalence rate of 6.1%. Moreover, sales of insulin injection pens for treating type 2 diabetes have surpassed sales of insulin vials, according to the National Institutes of Health (NIH). Injection devices are commonly utilized to self-administer insulin injections for diabetes treatment daily. Patients prefer using a pen injection method rather than a syringe to administer insulin from a vial because it is simpler. As a result, the growing occurrence of diabetes within the population has led to a rise in the use of injection pens.

The demand for injection pens has also surged due to the rising incidence of autoimmune diseases such as rheumatoid arthritis. The global prevalence of rheumatoid arthritis is approximately 0.5-1%, with biologic drugs requiring subcutaneous administration driving the adoption of injection pens. Similarly, growth hormone deficiencies, which require frequent injections, have contributed to market expansion, with pens offering better dosing accuracy and reduced administration discomfort.

Technological advancements are revolutionizing the market. Features such as dose memory, variable dosing, and ergonomic designs are enhancing patient adherence and convenience. For instance, in May 2024, the launch of Metoject Subcutaneous Injection Pen in Japan by Eisai Co., Ltd. and Nippon Medac Co., Ltd., a subsidiary of medac GmbH. This self-administrable methotrexate (MTX) pen for rheumatoid arthritis is the first of its kind in Japan. It aims to reduce patient burden and enhance the safety of self-injection. The product, available in varying dosages, received manufacturing and marketing approval in February 2024 and was added to Japan's National Health Insurance Drug Price List. With 700,000-800,000 patients with rheumatoid arthritis in Japan, this innovative pen addresses a critical therapeutic need.

The industry is witnessing significant regional expansion, driven by rising healthcare awareness and increasing prevalence of chronic diseases. In January 2024, Brazilian biopharmaceutical company Cristalia introduced a reusable pen injector for its biosimilar growth hormone, developed in collaboration with Nemera. Such partnerships highlight the focus on localized solutions to address specific market needs. In addition, rising investments in emerging markets, advancements in drug-delivery technologies, and demand for patient-friendly devices are fueling regional growth.

Global Injection Pen Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global injection pen market report based on product, application, end use, and region:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Disposable
  • Reusable
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Diabetes
  • Anaphylaxis
  • Osteoporosis
  • Growth Hormone Deficiency
  • Arthritis
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital
  • Clinics
  • Home Care Settings
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Country scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Region outlook
  • 2.3. Competitive Insights

Chapter 3. Injection Pen Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Injection Pen Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Injection Pen Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Injection Pen Market: Product Movement Analysis
  • 4.3. Injection Pen Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Disposable
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reusable
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Injection Pen Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Injection Pen Market: Application Movement Analysis
  • 5.3. Injection Pen Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Diabetes
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Anaphylaxis
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Osteoporosis
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Growth Hormone Deficiency
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Arthritis
    • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Injection Pen Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Injection Pen Market: End Use Movement Analysis
  • 6.3. Injection Pen Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospital
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Clinics
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Home Care Settings
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Injection Pen Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Injection Pen Market Movement Analysis
  • 7.3. Injection Pen Market: Regional Estimates & Trend Analysis by Product & Application
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Injection Pen Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. BD
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Eli Lilly and Company
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Ypsomed AG
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Biocon
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Pfizer Inc.
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Novartis AG
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Novo Nordisk A/S
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Sanofi
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Owen Mumford Ltd.
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Merck KGaA
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 4. Global injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 5. Global injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 6. North America injection pen market, by region, 2021 - 2033 (USD Billion)
  • Table 7. North America injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 8. North America injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 9. North America injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 10. U.S injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 11. U.S injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 12. U.S injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 13. Canada injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 14. Canada injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 15. Canada injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 16. Mexico injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 17. Mexico injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 18. Mexico injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 19. Europe injection pen market, by country, 2021 - 2033 (USD Billion)
  • Table 20. Europe injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 21. Europe injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 22. Europe injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 23. UK injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 24. UK injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 25. UK injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 26. Germany injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 27. Germany injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 28. Germany injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 29. France injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 30. France injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 31. France injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 32. Italy injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 33. Italy injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 34. Italy injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 35. Spain injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 36. Spain injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 37. Spain injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 38. Norway injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 39. Norway injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 40. Norway injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 41. Sweden injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 42. Sweden injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 43. Sweden injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 44. Denmark injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 45. Denmark injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 46. Denmark injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 47. Asia Pacific injection pen market, by country, 2021 - 2033 (USD Billion)
  • Table 48. Asia Pacific injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 49. Asia Pacific injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 50. Asia Pacific injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 51. Japan injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 52. Japan injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 53. Japan injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 54. China injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 55. China injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 56. China injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 57. India injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 58. India injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 59. India injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 60. Australia injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 61. Australia injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 62. Australia injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 63. South Korea injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 64. South Korea injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 65. South Korea injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 66. Thailand injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 67. Thailand injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 68. Thailand injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 69. Latin America injection pen market, by country, 2021 - 2033 (USD Billion)
  • Table 70. Latin America injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 71. Latin America injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 72. Latin America injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 73. Brazil injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 74. Brazil injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 75. Brazil injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 76. Argentina injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 77. Argentina injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 78. Argentina injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 79. Middle East & Africa injection pen market, by country, 2021 - 2033 (USD Billion)
  • Table 80. Middle East & Africa injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 81. Middle East & Africa injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 82. Middle East & Africa injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 83. South Africa injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 84. South Africa injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 85. South Africa injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 86. Saudi Arabia injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 87. Saudi Arabia injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 88. Saudi Arabia injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 89. UAE injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 90. UAE injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 91. UAE injection pen market, by end use, 2021 - 2033 (USD Billion)
  • Table 92. Kuwait injection pen market, by product, 2021 - 2033 (USD Billion)
  • Table 93. Kuwait injection pen market, by application, 2021 - 2033 (USD Billion)
  • Table 94. Kuwait injection pen market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Injection pen market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Injection pen market, product outlook key takeaways (USD Billion)
  • Fig. 12 Injection pen market product movement analysis, 2025 & 2033 (USD Billion)
  • Fig. 13 Disposable market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 14 Reusable market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 15 Injection pen market, application outlook key takeaways (USD Billion)
  • Fig. 16 Injection pen market application movement analysis 2025 & 2033 (USD Billion)
  • Fig. 17 Diabetes market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 18 Anaphylaxis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 19 Osteoporosis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 20 Growth hormone deficiency market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 21 Arthritis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 22 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 23 Injection pen market, end use outlook key takeaways (USD Billion)
  • Fig. 24 Injection pen market end use movement analysis 2025 & 2033 (USD Billion)
  • Fig. 25 Hospital market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 26 Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 27 Home care settings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 28 Injection pen market: Regional key takeaways (USD Billion)
  • Fig. 29 Injection pen market regional outlook, 2025 & 2033 (USD Billion)
  • Fig. 30 North America injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 31 US injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 32 Canada injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 33 Mexico injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 34 Europe injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 35 UK injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 36 Germany injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 France injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 38 Spain injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 39 Italy injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 40 Sweden injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 41 Norway injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 42 Denmark injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 43 Asia Pacific injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 China injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 45 Japan injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 India injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 47 South Korea injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 48 Australia injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Thailand injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 50 Latin America injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 Brazil injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 52 Argentina injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Middle East and Africa injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 South Africa injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 Saudi Arabia injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 UAE injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 57 Kuwait injection pen market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 List of key emerging company's/technology disruptors/innovators